| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |